This latest twist inside the Lykos Therapeutics saga threatens a major overhaul of the business’s method and direction, with Musk ally and billionaire investor Antonio Gracias showing up to would like to just take the business back again towards its nonprofit drug advancement roots and a more Doblinite philosophy.“creation” of a copyright Vap